Cargando…
Perampanel in brain tumor‐related epilepsy: Observational pilot study
OBJECTIVE: Possible loss of efficacy and potential interactions between antiepileptic drugs (AEDs) and chemotherapy could complicate the management of patients with brain tumor‐related epilepsy (BTRE) that may expose patients to an increased risk of adverse events. Perampanel (PER) is a highly selec...
Autores principales: | Maschio, Marta, Zarabla, Alessia, Maialetti, Andrea, Giannarelli, Diana, Koudriavtseva, Tatiana, Villani, Veronica, Zannino, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303381/ https://www.ncbi.nlm.nih.gov/pubmed/32285623 http://dx.doi.org/10.1002/brb3.1612 |
Ejemplares similares
-
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)
por: Coppola, Antonietta, et al.
Publicado: (2020) -
Impact of epilepsy and its treatment on brain metastasis from solid tumors: A retrospective study
por: Maschio, Marta, et al.
Publicado: (2022) -
Lacosamide on background eeg activity in brain tumor‐related epilepsy patients: A case series study
por: Maschio, Marta, et al.
Publicado: (2018) -
Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data
por: Maschio, Marta, et al.
Publicado: (2018) -
The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma
por: Maschio, Marta, et al.
Publicado: (2019)